Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Feb;56(2):528-32.
doi: 10.1111/trf.13346. Epub 2015 Sep 23.

Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products

Scott T Avecilla  1 , Steven M Marionneaux  1 , Tyler D Leiva  1 , Jo-Ann Tonon  1 , Virgil T Chan  1 , Christine Moung  1 , Richard C Meagher  1 , Peter Maslak  1
Affiliations
Comparative Study

Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products

Scott T Avecilla et al. Transfusion. 2016 Feb.

Abstract

Background: Allogeneic hematopoietic stem cell donor selection is based primarily on human leukocyte antigen degree of match and it often occurs without regard to the red blood cell (RBC) compatibility between donor and recipient. When major ABO-mismatched grafts are infused, it is imperative that an accurate determination of the incompatible RBC content is made to ensure that the product is safe for infusion. RBC content determination requires the hematocrit (Hct) parameter which can be obtained via manual (directly measured) or automated (calculated) methods.

Study design and methods: Ninety-seven apheresis hematopoietic progenitor grafts were assessed for Hct by manual testing and by four commercially available automated hematology analyzer instruments. A clinical model was developed to assess the frequency of unnecessary RBC reductions or alteration in standard infusion practice.

Results: Significant (p < 0.001) differences were observed where the manual Hct value was markedly lower than automated Hct values. At stringent incompatible RBC threshold of 10 mL, the number of preventable RBC reduction procedures ranged from 18% to 69%.

Conclusion: Accurate determination of RBC content of hematopoietic progenitor grafts is essential for patient safety. Despite the rapidity and convenience offered by automated Hct methods, they significantly overestimate the incompatible RBC content of grafts, which may trigger unnecessary RBC reduction procedures or split infusions. In products where automated Hct methods indicate excessive amounts of incompatible RBCs are present, we advise the performance of confirmatory testing with a manual Hct method to ensure that the automated Hct value is not a false positive.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Authors STA and SMM have received honoraria from Abbott Laboratories in association with presenting data from projects unrelated to the content of the manuscript submitted to TRANSFUSION. All other authors have no conflicts of interest relevant to the manuscript submitted to Transfusion.

Figures

Figure 1
Figure 1
Hematocrit (%) values for HPC(A) products using manual and automated HCT procedures
Figure 2
Figure 2
Hematocrit percent difference of automated analyzer as compared to the manual HCT test for HPC(A) products
See this image and copyright information in PMC

References

    1. Wingard JR, Wirk B, Brown R. Hematopoietic stem cell transplantation: An overview. In: McLeod BC, Szczepiorkowski ZM, Weinstein R, Winters JL, editors. Apheresis: Principles and practice. Bethesda: AABB Press; 2010. pp. 465–481.
    1. Buckner CD, Clift RA, Sanders JE, Williams B, Gray M, Storb R, Thomas ED. Abo-incompatible marrow transplants. Transplantation. 1978;26:233–238. - PubMed
    1. Bensinger WI, Buckner CD, Thomas ED, Clift RA. Abo-incompatible marrow transplants. Transplantation. 1982;33:427–429. - PubMed
    1. Rowley SD, Donato ML, Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2011;46:1167–1185. - PubMed
    1. Gutierrez-Aguirre CH, Gomez-De-Leon A, Alatorre-Ricardo J, Cantu-Rodriguez OG, Gonzalez-Llano O, Jaime-Perez JC, Mancias-Guerra C, Flores-Jimenez JA, Gomez-Almaguer D. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in abo-incompatible patients: Are survival and graft-versus-host disease different? Transfusion. 2014;54:1269–1277. - PubMed

Publication types

Substances